Hyperion Defi, Inc.
HYPD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001682639
No open-market purchases or sales by Hyperion Defi, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $7.92M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Hyperion Defi, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 28 | 28 | 0 |
| Shares | 1.97M | 4.08M | +2.11M (+107.5%) |
| Value | $7.86M | $12.5M | +$4.60M (+58.5%) |
New holders (2)
Institutions that held Hyperion Defi, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 2,296,621 | $7.00M | 0.20% |
| Hexagon Capital Partners LLC | 10,000 | $30.0K | 0.01% |
Sold out (2)
Institutions that held Hyperion Defi, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| HN Saltoro Capital, LP | 27,773 | $111.0K |
| Citadel Advisors LLC | 10,598 | $43.0K |